1. Characteristics of high‐ and low‐risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes. Issue 10 (6th June 2018) Authors: Tofte, N.; Lindhardt, M.; Adamova, K.; Beige, J.; Beulens, J. W. J.; Birkenfeld, A. L.; Currie, G.; Delles, C.; Dimos, I.; Francová, L.; Frimodt‐Møller, M.; Girman, P.; Göke, R.; Havrdova, T.; Kooy, A.; Mischak, H.; Navis, G.; Nijpels, G.; Noutsou, M.; Ortiz, A. Journal: Diabetic medicine Issue: Volume 35:Issue 10(2018) Page Start: 1375 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long‐term effects of metformin on endothelial function in type 2 diabetes: a randomized controlled trial. (16th September 2013) Authors: de, J.; Kooy, A.; Schalkwijk, C.; van der, J.; Lehert, P.; Bets, D.; Wulffelé, M. G.; Donker, A. J.; Stehouwer, C. D. A. Journal: Journal of internal medicine Issue: Volume 275:Number 1(2014:Jan.) Page Start: 59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗